This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William Silen, MD

Arch Surg. 1989;124(9):1021-1022.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the United States, during the past 5 to 10 years, there has been an increasingly aggressive surgical approach to resection of hepatic metastases from colorectal cancer. Operations for this purpose are currently the most common hepatic operation performed in this country, and the procedure is likely to become even more prevalent. It has been estimated that only about 1000 of the 6000 to 12 000 patients who might be potential candidates yearly actually have a resection.¹ While several series have reported 5-year survival rates of about 25% for those who undergo resection of hepatic metastases, comparison of this kind of outcome has been made only with retrospective series, a nonvalid control. Thus, it is not known whether surgical excision of these metastatic lesions is appropriate. A presentation and critical analysis of available data are made in this article in an attempt to provide some kind of rational approach to . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Surgery, Harvard Medical School and Beth Israel Hospital, Boston, Mass.

Footnotes
Accepted for publication April 28, 1989.

Reprint requests to Department of Surgery, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Silen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?